GSK Pharma Q2 net up 3 pc at Rs 99 cr
New Delhi : GlaxoSmithKline Pharmaceuticals reported 3.45 per cent rise in standalone net profit at Rs 98.85 crore for the second quarter ended September of the current fiscal.
It had posted net profit of Rs 95.55 crore for the July- September period of the previous fiscal, GSK Pharma said in a BSE filing.
Standalone total income from the operations also rose to Rs 799.12 crore for the quarter under review as against Rs 717.53 crore for the same period a year ago.
GSK Pharma stock was trading 0.48 per cent lower at Rs 2,906.05 per scrip in the afternoon trade on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd